Peregrine Pharmaceuticals is a clinical-stage biopharmaceutical company. Peregrine has a portfolio of cutting-edge monoclonal antibodies in clinical trials for treating cancer and infectious diseases, and the company is pursuing multiple cancer and hepatitis C virus infection clinical programs. The company additionally has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, which provides development and biomanufacturing services for outside customers as well as for Peregrine. For more information, visit the company’s Web site at www.peregrineinc.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: